![]() | ![]() |
Formats:
|
||||||||||||
Copyright © 2008 Okajima et al; licensee BioMed Central Ltd. Contributions of chaperone and glycosyltransferase activities of O-fucosyltransferase 1 to Notch signaling 1Nagoya University Graduate School of Bioagricultural Sciences, Department of Applied Molecular Biosciences, Furo-cho, Chikusa-ku, Nagoya 464-8601, Japan 2Howard Hughes Medical Institute, Waksman Institute and Department of Molecular Biology and Biochemistry, Rutgers The State University of New Jersey, Piscataway, NJ 08854, USA Corresponding author.Tetsuya Okajima: tokajima/at/agr.nagoya-u.ac.jp; BVVG Reddy: enu/at/waksman.rutgers.edu; Tsukasa Matsuda: tmatsuda/at/agr.nagoya-u.ac.jp; Kenneth D Irvine: irine/at/waksman.rutgers.edu Received June 4, 2007; Accepted January 14, 2008. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. This article has been cited by other articles in PMC.Abstract Background O-fucosyltransferase1 (OFUT1) is a conserved ER protein essential for Notch signaling. OFUT1 glycosylates EGF domains, which can then be further modified by the N-acetylglucosaminyltransferase Fringe. OFUT1 also possesses a chaperone activity that promotes the folding and secretion of Notch. Here, we investigate the respective contributions of these activities to Notch signaling in Drosophila. Results We show that expression of an isoform lacking fucosyltransferase activity, Ofut1R245A, rescues the requirement for Ofut1 in embryonic neurogenesis. Lack of requirement for O-fucosylation is further supported by the absence of embryonic phenotypes in Gmd mutants, which lack all forms of fucosylation. Requirements for O-fucose during imaginal development were evaluated by characterizing clones of cells expressing only Ofut1R245A. These clones phenocopy fringe mutant clones, indicating that the absence of O-fucose is functionally equivalent to the absence of elongated O-fucose. Conclusion Our results establish that Notch does not need to be O-fucosylated for fringe-independent Notch signaling in Drosophila; the chaperone activity of OFUT1 is sufficient for the generation of functional Notch. Background Notch proteins are receptors for a conserved intercellular signaling pathway that mediates a wide variety of cell-fate decisions during animal development [1]. Notch activity needs to be regulated precisely, and aberrant Notch activity is associated with a number of human diseases including cancers and congenital syndromes. Notch signaling is influenced by two conserved glycosyltransferases, O-fucosyltransferase1 (OFUT1) and Fringe (FNG) [2]. FNG transfers N-acetylglucosamine (GlcNAc) in a β1,3 linkage onto O-linked fucose on EGF domains [3,4]. Fringe was first identified because of its role in modulating Notch signaling during the development of the Drosophila wing, where it both potentiates the activation of Notch by one ligand, Delta, and inhibits the activation of Notch by another ligand, Serrate [5]. These opposing effects of Fringe on the activation of Notch by its ligands, together with the restriction of normal Fringe expression to dorsal wing cells, help to position a stripe of Notch activation along the dorsal-ventral (D-V) compartment boundary. This stripe of Notch activation is then essential for the further growth and patterning of the wing. Fringe also helps to regulate Notch activation in other Drosophila tissues; however, there are many Notch signaling events in Drosophila, such as the role of Notch in limiting the number of neural precursor cells (lateral inhibition) that are Fringe-independent. Similarly, vertebrate Fringe proteins are important regulators of Notch signaling in some contexts, but not in others [1,2]. OFUT1 catalyzes the transfer of fucose from GDP-fucose, the universal donor for fucosyltransferases, onto EGF domains [6]. It thus generates the O-linked fucose that is the substrate for FNG. Genetic studies of Ofut1 in flies, and its homolog Pofut1 in mice, have indicated that it has a much broader role in Notch signaling than FNG, and indeed appears to be universally required for all Notch signaling [7-9]. While this was initially taken to reflect a universal requirement for O-fucose on Notch, more recently a second function for OFUT1 was identified [10]. OFUT1 is a soluble ER protein [10,11] and, at least in Drosophila, acts as a Notch chaperone, facilitating the folding and secretion of Notch[10]. The fact that OFUT1 possesses both fucosyltransferase and chaperone activity for Notch raises the question of the respective contributions of these two activities to the genetic requirement for OFUT1 in Notch signaling. In this study, we have addressed this by examining the in vivo activity of Notch produced in cells with OFUT1 chaperone activity, but lacking fucosyltransferase activity. Surprisingly, we find that Notch expressed by these cells is a functional receptor. Our observations indicate that O-fucosylation is dispensable for many Notch signaling events during Drosophila development. Results O-fucosylation of Notch is not required during embryonic neurogenesis We have taken two complementary approaches to evaluate the respective contributions of the fucosyltransferase and chaperone activities of OFUT1 to Notch signaling. First, we employed a mutant isoform of OFUT1, OFUT1R245A. This mutation alters an invariant arginine within the putative GDP binding site, and it eliminates detectable fucosyltransferase activity, while retaining chaperone activity [10]. A genomic rescue construct carrying the Ofut1R245A mutation was created, and then introduced into flies by P element-mediated transformation. The ability of the OFUT1R245A isoform to rescue Notch signaling phenotypes was then assayed in animals lacking wild-type OFUT1. As Ofut1 is provided maternally to embryos, this was done by making germline clones with a null allele of Ofut1, Ofut14R6, in animals containing the Ofut1R245A genomic construct inserted on the same chromosome arm. In the absence of any rescue construct, animals lacking maternal and zygotic Ofut1 exhibit a strong neurogenic phenotype, in which impairment of lateral inhibition causes excess neurons to be produced at the expense of epidermal cells [9]. This phenotype is characteristic of mutations in Notch pathway genes and can be visualized by staining with antibodies against a marker for neuronal cells, ELAV (Figure (Figure1B,1B
As an independent test of the requirement for Notch fucosylation, we analyzed a mutant in which wild-type OFUT1 is present but unable to fucosylate Notch owing to the absence of its donor substrate, GDP-fucose. GDP-fucose is generated in the cytoplasm from GDP-mannose by enzymes including GDP-D-mannose dehydratase (GMD). Since Drosophila lack a salvage pathway for GDP-fucose synthesis [12], and GDP-fucose is the common donor substrate for all fucosyltransferases, animals lacking GMD are expected to be unable to effect all types of fucosylation. Animals that are mutant for a null allele of Gmd, Gmd1 [10], die as larvae with no neurogenic phenotype (not shown), but the survival of Gmd zygotic mutants could have been a result of maternally provided product. Thus, requirements for Gmd during embryonic development were evaluated by making germline clones. Confirmation of the general deficit in fucosylation in these embryos was provided by staining with anti-HRP antibodies, which recognize a fucose-containing epitope on neuronal N-glycans [13]. Anti-HRP staining was completely eliminated in animals lacking both maternal and zyogotic contributions of Gmd (Figure (Figure1D).1D Role of Notch O-fucosylation in the wing imaginal disk Notch signaling participates in many different processes throughout development and many of the factors that modulate Notch signaling are context specific. For example, fng is dispensable for Notch functions during embryonic neurogenesis, but plays a critical role in the developing wing. In the wing, fng is expressed by dorsal cells and its positive and negative effects on signaling by Delta and Ser, respectively, position a stripe of Notch activation along the edge of fng expression at the D-V boundary [5]. The critical role of fng in positioning Notch activation is evidenced by the observation that establishing novel fng expression boundaries by creating fng mutant clones in dorsal cells results in the induction of ectopic stripes of Notch activation, which can be visualized by examining expression of targets of Notch signaling, such as Wingless (WG; see Figure Figure2C)2C
To evaluate requirements for Notch O-fucosylation during wing development, we again took advantage of the ability to rescue the chaperone, but not the fucosyltransferase, activities of OFUT1 by expression of Ofut1R245A. Ofut1R245A was expressed in Ofut14R6 null mutant clones using two different methods. In one set of experiments, we expressed Ofut1R245A from a genomic rescue construct, such that Ofut1R245A was expressed under its own promoter. In an alternative approach, Ofut1R245A was over-expressed in Ofut14R6 mutant clones using the mosaic analysis with a repressible cell marker (MARCM) technique [16], which employs the UAS-Gal4 system to drive expression under the control of a heterologous promoter. Both methods yielded similar results: when Ofut1R245A expression is similar to endogenous Ofut1 levels, the rescued clones phenocopy fng mutant clones (Figures (Figures2E2E We also attempted to extend these observations by examining Gmd mutants. Animals that are mutant for a null allele, Gmd1, exhibit decreased growth and loss of WG expression in the wing imaginal disks, consistent with a deficit in Notch signaling [10]. To investigate whether this phenotype reflects a specific requirement for Gmd in FNG-dependent Notch signaling, or a more general requirement for Gmd in Notch signaling, we created clones of cells homozygous for Gmd1. However, in most cases these did not show obvious Notch-loss-of-function phenotypes (not shown). Only when the Minute technique was used to generate disks in which all, or almost all, of the wing was composed of mutant tissue was a loss of WG expression observed, and in all cases the loss of WG expression was non-autonomous (Figure (Figure2G).2G Over-expression of OFUT1 can inhibit Notch signaling independently of its fucosyltransferase activity Loss of Ofut1 impairs Notch signaling, but over-expression of Ofut1 can also impair Notch signaling [7]. This observation led to the suggestion that high levels of Notch O-fucosylation might suppress Notch signaling. However, the determination that it is the chaperone activity, rather than the fucosyltransferase activity, that is universally required for Notch signaling prompted us to re-examine the basis for the inhibition of Notch signaling associated with OFUT1 over-expression. Towards that end, Ofut1R245A was expressed at high levels in the developing notum under the control of ap-Gal4. Expression of wild-type Ofut1 (UAS-Ofut1 [8.2]) under ap-Gal4 control interferes with Notch-mediated lateral inhibition, and so results in the production of extra bristles (Figure (Figure3B,3B
OFUT1 is required for secretion of Notch from the ER The observation that the fucosyltransferase activity of OFUT1 is not required for all Notch signaling events implies that the previously described Notch chaperone activity of OFUT1 is its most critical function. Recently, however, our identification of this chaperone activity has been questioned and two additional activities for OFUT1 have been proposed in its place: the first, independent of its fucosyltransferase activity, promotes endocytosis of Notch from the plasma membrane to the early endosome [18]; the second, dependent upon fucosyltransferase activity, promotes trafficking of Notch from the plasma membrane to the sub-apical complex and adherens junctions [18]. The two most critical experiments distinguishing between the chaperone model and these trafficking models for OFUT1 function relate to the localization of Notch in cells lacking OFUT1. First, it was claimed that in contrast to our report that Notch is not secreted to the cell surface in the absence of OFUT1 [10], Notch is secreted to the plasma membrane in Ofut1 mutant cells [18]. This claim was based on an assay in which anti-Notch antibodies were added to live disks. However, this is not an effective assay for cell surface localization, because a cell surface receptor is not required for bulk endocytosis (e.g. even fluorescent dextran is efficiently endocytosed by disk cells [19]), and once endocytosed, antibodies could be spread throughout the secretory pathway and then accumulate wherever there are significant epitope concentrations. A standard assay for cell surface localization is to determine whether the accessibility of epitopes requires membrane permeabilization. Thus, we performed immunostaining using antibodies directed against the extracellular domain of Notch, both in the presence and in the absence of detergent. When wing disk cells are permeabilized with detergent, wild-type cells exhibit both intracellular staining as well as apical hexagonal staining, corresponding to the normal cell surface localization of Notch near the adherens junctions (Figures (Figures4A4A
The second critical piece of evidence presented against the chaperone model was a claim that the Notch that accumulates in Ofut1 mutant cells is not actually in the ER. This claim relies on the belief that the ER is homogeneous organelle, that is, that all ER proteins are homogeneously distributed. Both our studies [10] and those of Sasaki et al.[18] reveal overlap between Notch and ER markers in Ofut1 mutant or RNAi-depleted cells. At the same time, we agree that Notch does not overlap perfectly with ER markers in all focal planes; indeed, it is for this reason that we originally thought that Notch was not in the ER in the absence of OFUT1 [7]. However, we now think that differences between Notch and other markers reflect ER heterogeneity. In support of this idea, we have investigated the relative distributions of five different ER markers in wing imaginal disks cells: two dedicated ER chaperones (OFUT1 and Boca), a classic ER protein marker (Calnexin), a synthetic ER protein (GFP with a KDEL ER retention signal added) and bulk ER proteins (using an anti-KDEL antibody). Each of these ER markers exhibits partial, but not perfect, overlap with other ER markers (see Figures Figures4E4E Discussion The observations we describe here lead to the unexpected conclusion that the fucosyltransferase activity of OFUT1 is not essential for all Notch signaling in Drosophila. The lack of requirement for Notch O-fucosylation is evidenced by the observation that expression of a form of OFUT1 that provides chaperone activity, but lacks fucosyltransferase activity, is sufficient to enable Notch receptor activation in at least two different contexts: during embryonic neurogenesis, where Notch signaling effects lateral inhibition, and during wing disk development, where inductive Notch signaling establishes specialized D-V boundary cells. Indeed, because Ofut1R245A-rescued animals complete embryogenesis and hatch without grossly evident abnormalities, it is likely that many other Notch signaling events also do not require Notch fucosylation. Although reagents that would enable direct visualization of the O-fucosylation state of Notch in cells expressing Ofut1R245A do not exist, prior characterization of this mutant isoform indicates that it is completely defective in fucosylation [10]. Further, the observation of fng-like phenotypes in the wing provides a genetic argument that fucosylation is lacking in cells expressing only Ofut1R245A, as if O-fucose were present on Notch then it should be modified by FNG. Moreover, in a completely independent approach, the lack of requirement for Notch fucosylation was demonstrated by the observation of normal neurogenesis and completion of embryogenesis in Gmd mutants, whose general deficit in fucosylation was confirmed by anti-HRP staining. The absence of O-fucosylation in Gmd mutants is also consistent with the prior observation that Notch signaling at the D-V boundary of the wing is lost in Gmd mutants [10], as this is a fng-dependent process. Collectively, these results indicate that Notch receptors can transduce signals without modification by O-fucose. Prior results suggesting that O-fucose is required for Notch-ligand binding [9,15] can be explained by the requirement for the chaperone activity of OFUT1. Indeed, a bacterially expressed fragment of mammalian Notch1 can bind to Delta in spite of the absence of glycosylation [20]. The observation that O-fucose is not universally required for Notch signaling does not mean that it has no effect. In acting as a substrate for FNG, O-fucose clearly has an important modulatory role. It is, however, conceivable that this is the only absolute requirement for O-fucose, as genetic studies of the Ofut1R245A allele, as well as genetic studies of Gmd, are consistent with the possibility that all requirements for O-fucose might be explained by its role in FNG-dependent modulation of Notch: like Ofut1R245A-rescued animals, or Gmd maternal and zygotic mutant animals, fng mutant animals die as first instar larvae, without obvious affects on embryonic neurogenesis [21]. The apparently normal embryogenesis of Gmd mutants is particularly striking, as fucose is a common component of insect N-glycans. The similarity between Ofut1R245A-rescued clones and fng mutant clones in the wing is also informative in terms of the nature of the requirement for FNG modification. That is, the observation that loss of O-fucose results in the same phenotype as loss of O-fucose elongation implies that modulation of Notch signaling by FNG is affected because a specific glycan created as a consequence of FNG modification (i.e. elongated O-fucose) alters Notch-ligand interactions, rather than because elongation of O-fucose covers up a glycan (i.e. the O-fucose monosaccharide) that promotes Serrate-Notch interactions or impairs Delta-Notch interactions. Although the phenotypes of Ofut1R245A and Gmd might be explained simply by the requirement for FNG-dependent elongation, there are nonetheless some indications that the monosaccharide form of O-fucose can have an influence on Notch. In vitro binding revealed that elimination of the O-fucose modification site located in the ligand-binding region (EGF repeat 12) of Drosophila Notch causes elevated Serrate binding in the absence of Fringe [22]. Mutagenesis of the O-fucose site on EGF12 of Notch in mammalian cells also influenced Notch signaling, although in this case the result was an impairment of Delta-like 1 or Jagged-1 activation of Notch1 in cultured cells [23], and impaired Notch signaling in vivo (Ge and Stanley, personal communication). Moreover, the introduction of a novel O-fucosylation site on EGF repeat 14, as observed in the Nspl mutation, causes ectopic Notch activation during eye development, independently of Fringe activity [24]. These observations are, however, subject to the caveat that the affects of these mutations might not actually be a result of their effects on O-fucosylation. Cell-based ligand binding assays have revealed that a soluble form of Notch produced from cells over-expressing wild-type Ofut1 results in increased binding to Serrate but decreased binding to Delta [15], whereas Notch from Ofut1R245A over-expressing cells exhibits increased binding to both Serrate and Delta [10]. These differing affects of OFUT1 versus OFUT1R245A on Delta-binding suggest that increased O-fucosylation can modulate Notch-Delta interactions. A study of a Gmd-deficient mammalian cell line, Lec13, revealed that Jagged-1 dependent activation of Notch1 was reduced in the mutant cells, suggesting that O-fucose positively regulates Notch1 activation by Jagged-1 in this context [3,25]. Finally, we note that the expression of Ofut1 is developmentally regulated in Drosophila, exhibiting a complex spatial and temporal pattern [7]. Thus, while O-fucose is clearly not essential for all Notch signaling, it might still have a modulatory role in some contexts. Our studies have focused on the fucosyltransferase and the chaperone activities of OFUT1 as distinct functions, genetically separable by the R245A mutation. Nonetheless, from an evolutionary perspective it would be surprising if these activities were unrelated. Given that OFUT1 acts during the folding process and dissociates from EGF domains upon O-fucosylation, it is tempting to speculate that O-fucose might serve as a tag for correctly folded EGF domains, thus directing OFUT1 to incompletely folded EGF domains. Therefore, although O-fucosylation is not absolutely required for Notch receptor activity, it might still affect the efficiency of the chaperone activity of OFUT1. In support of this hypothesis, we have observed modest decreases in Notch secretion in S2 cells treated with double-stranded RNA corresponding to Gmd (Tetsuya Okajima, unpublished observations). Our studies also suggest the molecular basis for the previous observation that over-expression of OFUT1 inhibits Notch signaling [7]. We showed that over-expressed OFUT1 inhibits Notch signaling non-autonomously and non-enzymatically (Figure (Figure3).3 Conclusion In summary, our findings demonstrated for the first time that O-fucose modification on Notch receptors is not absolutely required for their activity in fringe-independent developmental processes in Drosophila, and that successful folding mediated by chaperone activity of OFUT1 is sufficient to generate functional Notch receptors. Methods Stocks Ofut14R6 was obtained from K Matsuno [9]. UAS-Ofut1R245A[28.3] and Gmd1 are described in [10]. The Gal4 drivers used were ptc-Gal4 (Flybase ID number; FBti0002124), ap-Gal4 (FBti0002785). UAS-iOfut1 [16.2], UAS-iOfut1 [12.3], UAS-Ofut1 [11.1] and UAS-Ofut1 [8.2] (insertion on chromosome 2) were obtained as described previously [7]. UAS-Ofut1 [11.1] provides stronger expression than UAS-Ofut1[8.2]. Genetics To obtain mutants lacking both maternal and zygotic Gmd, germline clones of Gmd1 were made by crossing Gmd1FRT 40A/CyO virgins to hs flp; ovoDFRT 40A/CyO males and heat shocking the progeny at 38°C for 1 h on two successive days during first and second larval instar. Then, hs flp; Gmd1FRT40A/ovoDFRT 40A female progeny that contained Gmd1 germline clones were crossed to Gmd1/CyO; twi-Gal4 UAS-GFP males. To obtain mutants lacking both maternal and zygotic Ofut1, germline clones of Ofut14R6 were made by crossing FRT42B [G13] Ofut14R6/CyO virgins to hs-flp [122]; FRT42B [G13] ovoD/CyO males and heat shocking the progeny at 38°C for 1 h on two successive days during the second and early third larval instar. Then, hs-flp [122]; FRT42B [G13] Ofut14R6/FRT42B [G13] ovoD female progeny that contained Ofut14R6 germline clones were crossed to FRT42B [G13] Ofut14R6/CyO, twi-Gal4 UAS-GFP males. To generate larger clone for Gmd1in disks, the Minute technique [27] was employed. M(2) Ubi-GFP FRT40A/CyO act-GFP flies were crossed to yflp; FRT40A Gmd1/CyO flies and the progeny were heat shocked at 38°C for 1 h during first larval instar. The homozygous Gmd1 cells produced by mitotic recombination lack the Minute mutation and, thus, divide more quickly than the surrounding cells heterozygous for Minute. The homozygous Minute clones cannot survive. To express Ofut1R245A in Ofut1 mutant backgrounds, the MARCM technique [27,28] was used. This technique allows the generation of mosaic clones that are mutant for one gene and expressing another gene under the control of a UAS promoter. Mosaic clones were generated by crossing y w hs-Flp [122] tub-Gal4 UAS-GFP:nls; FRT42B [G13] hsp:Myc tub-Gal80 [LL2]/CyO females to FRT42B [G13] Ofut14R6/CyO; UAS-Ofut1R245A [28.3]/TM6B males. The expression of Ofut1R245A is suppressed by the ubiquitous expression of the Gal80 transcriptional repressor. However, FRT-mediated mitotic recombination generating mutant clones for Ofut14R6 simultaneously removes tub-Gal80, which leads to disinhibition of Gal4 and, thus, drives the expression of both the GFP marker and Ofut1R245A. For genomic rescue experiments, a 3.8 kb BamHI/EcoRI fragment comprising the Ofut1 genomic sequence flanked by partial sequences of the neighboring genes CG8257 and CG8309, was cloned into the corresponding sites of pCasper. The R245A mutation was introduced by site directed mutagenesis (Stratagene). The resulting construct, pCasper-Ofut1R245A, was subjected to transposon-mediated germline transformation. To recombine with Ofut14R6, lines with insertions on the right arm of chromosome 2 were selected. Three lines, Ofut1R245A[18.1] (insertion; 43C), Ofut1R245A[33.1] (insertion; 53E) and Ofut1R245A[23.1] (insertion; 59A-C), are obtained. Among them, the expression was confirmed in Ofut1R245A[18.1] and Ofut1R245A[23.1]. As the recombination between Ofut1R245A[18.1] and FRT42B [G13] was difficult owing to the proximity of each insertion site, we used Ofut1R245A[23.1] for further analysis. For expression of GFP:KDEL in wing disk cells, the GFP:KDEL coding fragment was isolated by polymerase chain reaction (PCR) from pMT/Bip-GFP:KDEL [10], cloned into pUAST and transformed in to Drosophila. Antibody staining was performed essentially as described previously [5]. Antibodies used were mouse anti-WG (4D4, DSHB), mouse anti-Notch (C458.2H, DSHB), rat anti-ELAV (7E8A10, DSHB), rabbit anti-HRP (Cappel), rabbit anti-Notch (Intracellular Notch, E. Giniger), guinea pig anti-OFUT1 [10], guinea pig anti-Boca antibody [29], mouse anti-KDEL antibody (Stressgen) and rabbit anti-Calnexin antibody (Stressgen). Cell surface Notch staining For cell surface Notch staining of wing disks, third instar larvae were dissected and fixed for 30 min with the fixative solution containing 4% formaldehyde (Polysciences Inc. #18814), 0.1 M Pipes (pH7.2) and 50 mM NaCl. After washing three times for 5 min with phosphate buffered saline (PBS; 10 mM sodium phosphate, 2.7 mM KCl, 137 mM NaCl) followed by blocking with PBS plus 5% donkey serum (PBS-DS) for 30 min, disks were incubated with mouse anti-extracellular Notch (C458.2H; DSHB) in PBS-DS overnight. After washing with PBS (three times for 5 min) followed by blocking with PBS-DS for 30 min, disks were incubated for 3 h with Cy3-conjugated donkey anti-mouse IgG (Jacson Laboratories) in PBS-DS containing 0.05% BSA and 0.005% Triton-X 100, and then washed three times for 5 min with PBS containing 1% BSA and 0.1% Triton-X 100 (PBT). List of abbreviations A-P, anterior-posterior; D-V, dorsal-ventral; FNG, Fringe; GlcNAc, N-acetylglucosamine; GMD, GDP-D-mannose dehydratase; MARCM, mosaic analysis with a repressible cell marker; OFUT1, O-fucosyltransferase1; PBS, phosphate buffered saline; PBS-DS, PBS plus 5% donkey serum; PCR, polymerase chain reaction; WG, Wingless. Authors' contributions TO performed genetic and histochemical analyses in Figures Figures1,1 Additional file 1 Distribution of various ER markers in the wing disks. Vertical section is shown with apical up in all panels. (A) UAS-iOfut1 [16.2]; ptc-Gal4 wing disk immunostained with OFUT1 (green) and Calnexin (magenta). This line exhibits only partial silencing of OFUT1 expression, visible on the left-hand side of the panel. (B), (C) Immunostaining of wild-type wing disks with (B) Boca (green) and Calnexin (magenta) or (C) OFUT1 (green) and KDEL (magenta). (D), (E) Wing disks expressing GFP:KDEL (magenta) under ptc-Gal4 control are immunostained with (D) Boca or (E) OFUT1. (F), (G) UAS-iOfut1 [12.3]; ptc-Gal4 wing disks raised at 29°C are immunostained with Notch (magenta) and (F) KDEL or (G) Boca (green). The dashed line marks the edge of the ptc expression stripe. Click here for file(4.9M, TIFF) Acknowledgements We thank R Mann, K Matsuno, the Bloomington Drosophila stock center and the Developmental Studies Hybridoma Bank for flies and for antibodies. Thanks also go to R Haltiwanger and P Stanley for comments on the manuscript. This work was supported by grants from: the Japanese Ministry of Education, Science, Sports, and Culture; Uehara Memorial Foundation; Takeda Science Foundation; Nakajima Foundation; Human Frontier Science Program (to TO); and by the Howard Hughes Medical Institute (to KDI). References
|
PubMed related articles
Your browsing activity is empty. Activity recording is turned off. |
|||||||||||
Nat Rev Mol Cell Biol. 2006 Sep; 7(9):678-89.
[Nat Rev Mol Cell Biol. 2006]Nat Rev Mol Cell Biol. 2003 Oct; 4(10):786-97.
[Nat Rev Mol Cell Biol. 2003]Nature. 2000 Jul 27; 406(6794):369-75.
[Nature. 2000]Nature. 2000 Jul 27; 406(6794):411-5.
[Nature. 2000]Nature. 1997 Jun 26; 387(6636):908-12.
[Nature. 1997]Nat Rev Mol Cell Biol. 2006 Sep; 7(9):678-89.
[Nat Rev Mol Cell Biol. 2006]J Biol Chem. 1998 Apr 3; 273(14):8112-8.
[J Biol Chem. 1998]Cell. 2002 Dec 13; 111(6):893-904.
[Cell. 2002]Development. 2003 Oct; 130(20):4785-95.
[Development. 2003]Science. 2005 Mar 11; 307(5715):1599-603.
[Science. 2005]J Biol Chem. 2005 Mar 25; 280(12):11289-94.
[J Biol Chem. 2005]Science. 2005 Mar 11; 307(5715):1599-603.
[Science. 2005]Development. 2003 Oct; 130(20):4785-95.
[Development. 2003]J Biol Chem. 2002 Feb 1; 277(5):3168-75.
[J Biol Chem. 2002]Science. 2005 Mar 11; 307(5715):1599-603.
[Science. 2005]J Biol Chem. 1991 Mar 5; 266(7):4168-72.
[J Biol Chem. 1991]Nature. 1997 Jun 26; 387(6636):908-12.
[Nature. 1997]Nature. 1996 Jul 11; 382(6587):133-8.
[Nature. 1996]Development. 2003 Oct; 130(20):4785-95.
[Development. 2003]J Biol Chem. 2003 Oct 24; 278(43):42340-5.
[J Biol Chem. 2003]Trends Neurosci. 2001 May; 24(5):251-4.
[Trends Neurosci. 2001]Science. 2005 Mar 11; 307(5715):1599-603.
[Science. 2005]Development. 1997 Aug; 124(16):3055-64.
[Development. 1997]Cell. 2002 Dec 13; 111(6):893-904.
[Cell. 2002]Genes Cells. 2007 Jan; 12(1):89-103.
[Genes Cells. 2007]Genes Cells. 2007 Jan; 12(1):89-103.
[Genes Cells. 2007]Science. 2005 Mar 11; 307(5715):1599-603.
[Science. 2005]Genes Cells. 2007 Jan; 12(1):89-103.
[Genes Cells. 2007]Development. 2004 Nov; 131(22):5527-37.
[Development. 2004]Science. 2005 Mar 11; 307(5715):1599-603.
[Science. 2005]Genes Cells. 2007 Jan; 12(1):89-103.
[Genes Cells. 2007]Cell. 2002 Dec 13; 111(6):893-904.
[Cell. 2002]J Biol Chem. 2005 Mar 25; 280(12):11289-94.
[J Biol Chem. 2005]Science. 2005 Mar 11; 307(5715):1599-603.
[Science. 2005]Development. 2003 Oct; 130(20):4785-95.
[Development. 2003]J Biol Chem. 2003 Oct 24; 278(43):42340-5.
[J Biol Chem. 2003]Structure. 2004 Dec; 12(12):2173-83.
[Structure. 2004]Cell. 1994 Nov 18; 79(4):595-606.
[Cell. 1994]Development. 2003 Dec; 130(26):6411-21.
[Development. 2003]J Biol Chem. 2005 Sep 16; 280(37):32133-40.
[J Biol Chem. 2005]Development. 2003 Jul; 130(13):2829-40.
[Development. 2003]J Biol Chem. 2003 Oct 24; 278(43):42340-5.
[J Biol Chem. 2003]Science. 2005 Mar 11; 307(5715):1599-603.
[Science. 2005]Cell. 2002 Dec 13; 111(6):893-904.
[Cell. 2002]Science. 2005 Mar 11; 307(5715):1599-603.
[Science. 2005]J Biol Chem. 1998 Apr 3; 273(14):8112-8.
[J Biol Chem. 1998]Development. 2007 Apr; 134(7):1347-56.
[Development. 2007]Development. 2003 Oct; 130(20):4785-95.
[Development. 2003]Science. 2005 Mar 11; 307(5715):1599-603.
[Science. 2005]Cell. 2002 Dec 13; 111(6):893-904.
[Cell. 2002]Development. 2003 Nov; 130(21):5065-72.
[Development. 2003]Development. 2003 Nov; 130(21):5065-72.
[Development. 2003]Neuron. 1999 Mar; 22(3):451-61.
[Neuron. 1999]Science. 2005 Mar 11; 307(5715):1599-603.
[Science. 2005]Nature. 1997 Jun 26; 387(6636):908-12.
[Nature. 1997]Science. 2005 Mar 11; 307(5715):1599-603.
[Science. 2005]Cell. 2003 Feb 7; 112(3):343-54.
[Cell. 2003]